依达拉奉治疗急性脑梗死的临床疗效观察

目的临床观察依达拉奉注射液治疗急性脑梗死的疗效。方法将60例急性脑梗死患者分为对照组和治疗组,各30例,对照组为常规治疗,治疗组在常规治疗上给予静脉依达拉奉治疗,对比分析两组NIHSS评分和临床疗效。结果治疗组与对照组神经功能缺损评分总有效率经统计学处理有显著性差异(P<0.05)。结论依达拉奉注射液治疗急性脑梗死可改善临床神经功能缺损程度,提高日常生活能力,是治疗急性脑梗死的有效方法。

Clinical Research about Edaravone in Acute Cerebral Infarction

Objective To evaluate the efficacy and adverse reactions of Edaravone in the treatment of acute cerebral infarction（ACI）.Methods A randomized controlled study on 60 patients with ACI.They were allocated into treatment group（n= 30） and control group（n= 30）.Patients in both groups were given regular treatment.Patients in treatment group also received Edaravone injection 30 mg twice per day for 14 days.Then eurological deficits of patients in both groups were assessed by NIHSS respectively before and after the treatment.Clinical efficacy was evaluated according to changes NIHSSscores on the14d.Results There was a significant difference NIHSS between treatment group and controlgroup（P0.05）.There was no distinct adverse reaction seen in these two groups.Conclusion Edaravone can improve impaired neurological function and activities of daily living in patients with acute cerebral infarction without obviously adverse reaction.Edaravone is effective and safe in the treatment of patients with acute cerebral infarction.It is worthy to be recommen